Dr. Malhotra on Calling for Vaccine Data Transparency

 What was reported in the mainstream news as being 95 percent effective against infection was in fact relative risk reduction, not absolute risk reduction from the double blind randomized controlled trial that took place during the more lethal circulating post-Wuhan ancestral strain of the virus. The specific NEJM paper which underpinned the emergency use authorization of the Pfizer mRNA vaccine actually revealed an absolute risk reduction of 0.84 percent. In other words, for every 119 individuals vaccinated, one person would be protected from being infected.